Home > Boards > US Listed > Medical - Drugs >

Phio Pharmaceuticals Corp (PHIO)

PHIO RSS Feed
Add PHIO Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 12/2/2020 11:09:53 AM - Followers: 135 - Board type: Free - Posts Today: 0

About RXi Pharmaceuticals

RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform.  Therapeutics that use RNA interference, or "RNAi," have great promise because of their ability to "silence," or down-regulate, the expression of a specific gene that may be overexpressed in a disease condition.  Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, RXi's first RNAi product candidate, RXI-109, entered into RXi's first human clinical trial in 2012.  RXI-109 targets connective tissue growth factor (CTGF), a key regulatory of fibrosis and scar formation, and is initially being developed to reduce or inhibit scar formation in the skin following surgery.
 

 



RXi Pharmaceuticals Corp., has received patent approval for their new experimental breast cancer vaccine which became part of the company's arsenal after acquiring Apthera Inc. in April of this year.
The specific patents in question regard using the vaccine NeuVax with the drug Herceptin which is used in women to slow the production of the HER2 protein in tumors, while NeuVax attempts to make the body's immune system fight off cancerous cells.
According to The Telegram:
"The patents also cover using NeuVax in patients not eligible for Herceptin treatment."
With their patent in place the company plans to begin human tests in early 2012.
According to RXi the patents were developed by Dr. George E. Peoples, director of the Cancer Vaccine Development Program for the U.S. Military Cancer Institute and RXi is leasing the patents for their own work.
 

 



This May, RXi Pharmaceuticals Corp. observed two momentous events: The biotechnology company completed its spinoff from Galena Biopharma Inc., and Dr. Geert Cauwenbergh took the helm as president and chief executive officer. The small company's first product, an anti-scarring medication called RXI-109, entered clinical trials this year, and is based on the pioneering work in RNA interference of RXi scientific founder and Nobel Laureate Dr. Craig C. Mello. Dr. Cauwenbergh came to RXi after a long career in pharmaceuticals, most recently as president and chief executive officer of a company he founded, Barrier Therapeutics. What attracted you to come to Worcester? "It was the technology, well, the technology and the chemistry with these people. They're very bright." As a publicly traded company, how do you reconcile the needs of the investors, which are sometimes a short-term desire for profits, with the needs of medical research, which sometimes takes years? "Through business development. Basically what you do as a small biotech is you try to create a big network with people who have interest in various stages of development. ... In two or three years they get antsy and they want to cash in, but at that point in time there will be and there is already a network of business development contacts in place where you can for instance get nondiluted money without having to raise money and go back to the stock market and shareholders by making regional deals or geographic deals ...

NEWS

June 9, 2015 RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Novel RNAi Platform

http://finance.yahoo.com/news/rxi-pharmaceuticals-strengthens-intellectual-property-110200033.html

Dec 17, 2014 RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301

http://finance.yahoo.com/news/rxi-pharmaceuticals-announces-sustained-effect-120200746.html

Press Releases
RXi Pharmaceuticals to Present at Biotech Showcase™ 2013 - December 19, 2012
RXi Pharmaceuticals Announces Initiation of Second Double-Blind Vehicle Controlled Phase 1 Study With Its Anti-Scarring Compound, RXI-109 - December 5, 2012
RXi Pharmaceuticals Announces Pharmacokinetic Results of its Single Dose Phase 1 Study with RXI-109 in Healthy Volunteers - November 15, 2012
RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2012 - November 14, 2012
RXi Pharmaceuticals to Present at 12th Annual Biotech Symposium - October 16, 2012
RXi Pharmaceuticals Awarded NCI SBIR Funding to Advance Self-Delivering RNAi Technology - October 4, 2012
RXi Pharmaceuticals to Present at 11th Annual BIO Investor Forum - October 2, 2012
RXi Pharmaceuticals Announces Completion of Dosing in Phase 1 Trial for RXI-109 Program - September 24, 2012
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2012 - August 15, 2012
RXi Pharmaceuticals Appoints Jeannette Graf MD and Leroy Young MD to its Scientific Advisory Board - July 13, 2012
 
Share Statistics
Avg Vol (3 month)3: 215,443
Avg Vol (10 day)3: 145,371
Shares Outstanding5: 338m
Float: 53.34M
% Held by Insiders1: 9.01%
% Held by Institutions1: 0.50%
 



http://www.rxipharma.com/

 
PHIO
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PHIO News: Current Report Filing (8-k) 11/10/2020 05:02:01 PM
PHIO News: Quarterly Report (10-q) 11/10/2020 05:01:31 PM
PHIO News: Current Report Filing (8-k) 10/13/2020 04:31:05 PM
PHIO News: Additional Proxy Soliciting Materials (definitive) (defa14a) 08/28/2020 05:01:58 PM
PHIO News: Proxy Statement (definitive) (def 14a) 08/28/2020 05:01:21 PM
PostSubject
#4917   PHIO 70% of the Daily Volume is being Stockexpertpro 12/02/20 11:09:53 AM
#4916   PHIO 50-55% Cancer Survival VS just 10-15% With Stockexpertpro 12/01/20 12:23:54 PM
#4915   150 Million Volume on a 4.6 Million Share Stockexpertpro 12/01/20 12:22:46 PM
#4914   agree warrant price 1.10 and stock price in [SMART MONEY] 10/28/20 05:12:46 PM
#4913   Someone make a mistake with the warrants again? The Other Guy 10/28/20 05:06:20 PM
#4912   .04 TO 1.10 NOE THATS CRAZEEEEEE [SMART MONEY] 10/28/20 04:25:24 PM
#4911   Gerrit, where is the PH-762 ACT update? The Other Guy 09/30/20 10:17:00 AM
#4910   * * $PHIO Video Chart 09-17-2020 * * ClayTrader 09/17/20 04:31:23 PM
#4909   Wrong board. But I do see the The Other Guy 09/03/20 09:13:55 AM
#4908   We’re at discount pricing for the afternoon. The Other Guy 09/02/20 11:42:25 AM
#4907   Does Gerrit actually know how to run a The Other Guy 08/12/20 07:03:55 PM
#4906   Another pump and dump. The company currently has The Other Guy 08/12/20 12:35:26 PM
#4905   Theybare due fur news l2 BEIJING BILL 08/11/20 12:16:01 PM
#4904   PHIO $9 pop if next days COVID-19 News l2 hunter 08/11/20 11:53:26 AM
#4903   110 purcent agreed BEIJING BILL 08/11/20 11:49:33 AM
#4902   $PHIO time to break $3.15 and retest those 5's. Ownwallstreet 08/11/20 11:40:50 AM
#4901   3.13 BEIJING BILL 08/10/20 01:42:33 PM
#4900   PHIO $9 my first goal after next COVID19 News l2 hunter 08/10/20 01:38:10 PM
#4899   There she goes 3.05 BEIJING BILL 08/10/20 01:29:51 PM
#4898   $PHIO Phio Pharmaceuticals (PHIO) mick 08/07/20 04:20:48 PM
#4897   Looks like we finaly going in position for l2 hunter 08/07/20 12:18:39 PM
#4896   My 2.66 turned into 2.90 BEIJING BILL 08/07/20 12:11:07 PM
#4895   I stil holding here. Lets see 3 plus BEIJING BILL 08/07/20 09:38:37 AM
#4894   Have also load some PHIO. Maybe next huge l2 hunter 08/04/20 12:43:20 AM
#4893   $PHIO FOLLOWING DA MONEY !!!!! mick 08/03/20 03:23:35 PM
#4892   SFET check chart alchemytrader 08/03/20 02:32:50 PM
#4891   Im gong to pik up a few here BEIJING BILL 08/03/20 02:21:40 PM
#4890   Ate small loss on this turd on that alchemytrader 07/17/20 09:14:49 PM
#4889   Only one making any money from this company The Other Guy 07/14/20 06:53:21 PM
#4888   This ticker...smh,rxii,mello,Nobel prize...for what???? the submariner 07/14/20 02:58:50 PM
#4887   :-( alchemytrader 07/09/20 06:59:43 PM
#4886   The company cannot release a morsel of positive The Other Guy 07/09/20 06:55:00 PM
#4885   getting some attention here a/h. alchemytrader 07/09/20 04:42:49 PM
#4884   ~***Very Low Float***with Updates Looming... VMB-1 06/09/20 03:41:47 PM
#4883   Clay do you think PHIO Will go back Ivegotanace2 06/03/20 11:24:37 PM
#4882   PHIO Sure separated to the down side. 3 Ivegotanace2 06/03/20 01:15:40 PM
#4881   Definitely a p & D .. They got Ivegotanace2 06/01/20 03:15:30 PM
#4880   Not so much LoL it went below $3 Ivegotanace2 05/29/20 05:08:15 PM
#4879   * * $PHIO Video Chart 05-29-2020 * * ClayTrader 05/29/20 04:56:31 PM
#4878   Looks tempting on dip. UP Trend 05/29/20 01:17:23 PM
#4877   Strong / Today Easy 10 - 20+ US$ Amazing Tomasmith 05/29/20 09:02:53 AM
#4876   Phio Announces Positive In Vivo Data on the subslover 05/29/20 08:32:29 AM
#4875   A company with 5 R/S..yes 5!...should NEVER be NGIN 04/22/20 05:20:07 PM
#4874   COULD BE AN OTC STOCK SOON edwardport 03/31/20 08:00:14 PM
#4873   This BIO SCAM sure did imo Thats ALL NGIN 03/31/20 01:31:19 PM
#4872   Company screwed investors today. Release positive news and The Other Guy 03/31/20 01:19:43 PM
#4871   Could really get going over 3.70 or so. eebbee 03/31/20 07:54:16 AM
#4870   PR Newswire March 31, 2020, 6:30 am Animal studies show Beano1969 03/31/20 07:47:20 AM
#4869   CV play ?? shurtha2000 03/11/20 11:00:15 AM
#4868   Read yesterday’s news... Liquid1974 03/11/20 07:27:14 AM
PostSubject
Consent Preferences